RegistriesIncidenceRisk FactorsTreatment OutcomeUnited StatesTime FactorsRetrospective StudiesNeoplasmsFollow-Up StudiesCohort StudiesProspective StudiesRisk AssessmentDenmarkAge FactorsSEER ProgramForecastingSurvival RateEuropeInfant, NewbornAge DistributionDatabases, FactualSurvival AnalysisPrognosisHospital MortalityNorwaySwedenRare DiseasesLogistic ModelsSex FactorsPopulation SurveillanceProportional Hazards ModelsMyocardial InfarctionAngioplasty, Balloon, CoronaryMultivariate AnalysisPatient SelectionBreast NeoplasmsGermanyMedical Record LinkageQuestionnairesSex DistributionOdds RatioKaplan-Meier EstimateStrokeData CollectionResearch DesignFrancePrevalenceDrug-Eluting StentsRiskHospital RecordsItalyAustraliaDiseases in TwinsJapanChi-Square DistributionCause of DeathCase-Control StudiesCaliforniaComorbiditySeverity of Illness IndexCanadaHospitalizationPregnancySpainOutcome Assessment (Health Care)StentsMedical RecordsInternational CooperationClinical Trials as TopicReproducibility of ResultsPredictive Value of TestsSurvivorsNetherlandsTwins, DizygoticCongenital AbnormalitiesTwins, MonozygoticFinlandCardiovascular AgentsRandomized Controlled Trials as TopicRegression AnalysisGreat BritainNorth AmericaConfidence IntervalsDeath CertificatesPercutaneous Coronary InterventionNeoplasm StagingSwitzerlandCoronary Artery DiseaseRecurrenceInternationalityProduct Surveillance, PostmarketingAcute Coronary SyndromeEpidemiologic MethodsClinical CodingPostoperative ComplicationsWounds and InjuriesEthnic GroupsMichiganSocieties, MedicalProsthesis Design